Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
No negative interaction [26]
Safety in TRIUMPH-1 The safety profile was consistent with incretin-class therapies: Most common AEs (12 mg dose): - Nausea: 42.4% - Diarrhea: 32.0% - Constipation: 26.1% - Vomiting: 25.3% Dysesthesia (a sensory disturbance tingling, numbness) and urinary tract infections were reported in approximately 10% of patients on the highest doses, but were generally mild to moderate and mostly resolved during treatment
Keep your basic habits steady
2017;26:62032 (e6)
US$ 28.01
US$ 26.53
US$ 23.16
US$ 24.56
US$ 25.82
:max_bytes(150000):strip_icc():focal(504x0:506x2)/kim-kardashian-6-dc0c4750758b4163ae1c02b2d59978df.jpg)
